Monthly Archives: August 2016

In 2 phase II open-label clinical trials, the combination of ABT-493 (NS3/4A protease inhibitor) plus ABT-530 (NS5A inhibitor) achieved sustained virologic response in 96%-100% of patients with HCV genotype 1 or 3 infection and compensated cirrhosis. Continue reading →

We are in agreement with Daher et al1 in finding hemochromatosis patients with moderate iron overload who are heterozygous for mutations in the BMP6 pro-peptide. Our unit carries out comprehensive genetic testing for disorders of iron metabolism. This… Continue reading →

We are in agreement with Daher et al1 in finding hemochromatosis patients with moderate iron overload who are heterozygous for mutations in the BMP6 pro-peptide. Our unit carries out comprehensive genetic testing for disorders of iron metabolism. This… Continue reading →

We are in agreement with Daher et al1 in finding hemochromatosis patients with moderate iron overload who are heterozygous for mutations in the BMP6 pro-peptide. Our unit carries out comprehensive genetic testing for disorders of iron metabolism. This… Continue reading →

Question: A 51-year-old Hispanic woman from Mexico presented to the health department as part of a tuberculosis (TB) contact investigation. Her father had recently died of pulmonary TB. She reported a nonproductive cough for 1–2 weeks. A faint, left … Continue reading →

Question: A 51-year-old Hispanic woman from Mexico presented to the health department as part of a tuberculosis (TB) contact investigation. Her father had recently died of pulmonary TB. She reported a nonproductive cough for 1–2 weeks. A faint, left … Continue reading →

Question: A 51-year-old Hispanic woman from Mexico presented to the health department as part of a tuberculosis (TB) contact investigation. Her father had recently died of pulmonary TB. She reported a nonproductive cough for 1–2 weeks. A faint, left … Continue reading →

Question: A 48-year-old man who received a diagnosis of chronic hepatitis B 20 years ago but was not regularly followed up. He recently received a diagnosis of hepatocellular carcinoma (HCC). The initial presentation was poor appetite and abdominal pai… Continue reading →

Question: A 48-year-old man who received a diagnosis of chronic hepatitis B 20 years ago but was not regularly followed up. He recently received a diagnosis of hepatocellular carcinoma (HCC). The initial presentation was poor appetite and abdominal pai… Continue reading →

Question: A 48-year-old man who received a diagnosis of chronic hepatitis B 20 years ago but was not regularly followed up. He recently received a diagnosis of hepatocellular carcinoma (HCC). The initial presentation was poor appetite and abdominal pai… Continue reading →